Biogen Inc (BSP:BIIB34)
R$ 169.49 1.36 (0.81%) Market Cap: 149.37 Bil Enterprise Value: 178.06 Bil PE Ratio: 15.80 PB Ratio: 1.56 GF Score: 75/100

Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP Transcript

Sep 23, 2020 / 05:00PM GMT
Release Date Price: R$245.7
Peter Goadsby;University of California;Professor of Neurology

We're at the top of the hour, and I'm hoping that my video and sound is working. If something's not working, I hope the AAN folks will tell me.

Welcome, everyone who's online. It's pretty exciting to be at the academy. It always is for the emerging science. I can't pretend that it's not more exciting to be sitting cheek to jowl in a room. But it's pretty exciting to be sitting here listening to the abstracts. There's a lot of very cool stuff.

I'll remind you that these abstracts scored at the absolute top. This is what peers thought was really great science. So it's just going to be a fantastic collection of presentations.

I'm Peter Goadsby. I'm a neurologist at UCLA and at King's in London. I don't have to read the usual sorts of things. You don't have to mute because everyone's turned off. You probably ought not smoke. But I guess it's your house, so whatever you want to do.

We don't advise Amazon Shopping or any -- or -- and I guess if you want to ride a bike or something like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot